Navigation Links
Acquisitions, Clinical Trial Results, Date Extensions and Financial Results - Research Report on Endo, Astex, Auxilium, Accuray, and BioScrip
Date:9/2/2013

: [http://www.investorsreports.com/report/2013-08-28/ENDP]

--

Astex Pharmaceuticals, Inc. Research Report

On August 28, 2013, Astex Pharmaceuticals, Inc. (Astex) reported topline results from the ongoing Phase 2 trial of SGI-110 in patients with AML and MDS. The Company stated that as of the end of the June 2013 data cutoff, 67 AML patients had a minimum follow up of 3 months (50 patients representing the complete cohort of relapsed/refractory AML, and 17 patients in the treatment-naïve elderly AML not suitable for induction chemotherapy cohort). According to Astex, the primary endpoint was overall remission rate (Complete Remission or CR Complete Remission with Incomplete hematologic recovery or CRi/CRp), and there were 8 remissions in relapsed/refractory AML and 9 remissions in treatment-naïve elderly AML for an overall complete remission rate of (CR, CRi/CRP0 of 17/67) or 25%. The Full Research Report on Astex Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-08-28/ASTX]

--

Auxilium Pharmaceuticals, Inc. Research Report

On August 28, 2013, Auxilium Pharmaceuticals, Inc. (Auxilium) announced that the U.S. Food and Drug Administration (FDA) has notified the Company that it is extending the Prescription Drug Fee User Act (PDUFA) goal date for the Company's supplemental biologics license application (sBLA) for XIAFLEX (collagenase clostridium histolyticum) for the treatment of Peyronie's disease (PD) from September 6, 2013 to December 6, 2013. Commenting on the extension, Adrian Adams, CEO and President of Auxilium Pharmaceuticals, said, "While we are disappointed in any delay of approval, we remain confident in the XIAF
'/>"/>

SOURCE Investors' Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Verum.de Exhibits at Outsourcing in Clinical Trials Southern California
2. Leading the Site CTMS Market: Clinical Conductor CTMS Reaches 1,600 Sites
3. Clinovo Sponsors Outsourcing in Clinical Trials Southern California Conference 2013, in La Jolla (CA), September 24-25
4. Mytrus Electronic Informed Consent System Selected for 2013 Product Leadership Award in Clinical Trials
5. In Vitro Safety Screening for Clinical Liabilities, New Life Science Webinar hosted by Xtalks
6. ACRES Launches Global Clinical Research Network Technology Platform
7. Oncopeptides Initiates Phase II Clinical Study with Melflufen in the Treatment of Multiple Myeloma Patients
8. Indiana University Contracts with Virtify for Clinical Trial Disclosure Solutions
9. LabAnswer and OpGen Implement the STARLIMS Cloud Platform to Support OpGen’s CLIA Certified Clinical Services Laboratory in Under Four Months
10. Study Scavenger and CenterWatch Partner to Improve Patient Recruitment, Enrollment and Mobile Access to Clinical Trials with New Study Scavenger Smartphone App
11. MD Biosciences Offers IL-23-Induced Psoriasis-Like Preclinical Model for Skin Inflammation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , 22. Juli 2014 Qforma, ein ... die Ernennung von Marcus Bergler zum General Manager ... hat die europäischen kommerziellen Aktivitäten von Qforma bereits ... sich Qforma anschloss, war er in Positionen als ... als Vertriebsteam-Leiter Deutschland bei IMS Health und als ...
(Date:7/22/2014)... Greenville, SC (PRWEB) July 22, 2014 ... chorus of those who have recognized that the greatest ... inefficient, and far too often needlessly deadly while trying ... the multitude of quasi-experts seeking to transform an enormous ... detail.” , Dr. Williams, in his continuing series of ...
(Date:7/21/2014)... the right amount of tension to a chain of ... to an insulator, according to Rice University scientists. , ... one-dimensional chain of carbon atoms -- by just 3 ... that engineers might find useful for mechanically activated nanoscale ... physicist Boris Yakobson and his colleagues appears in the ...
(Date:7/21/2014)... 2014  Mike Patterson, CEO of Graphene Frontiers, ... Series Seed B funding to finance production of ... life science, defense, intelligence, and environmental industries.  A ... round and was joined by R2M Investments.  Return ... , "This round of funding will ensure Graphene ...
Breaking Biology Technology:Qforma gibt Schaffung des neuen Postens als General Manager in Europa bekannt 2Dr. Ira Williams Asks What’s Wrong With Jonathan Bush’s Book, Where Does It Hurt? 2Carbyne morphs when stretched 2Carbyne morphs when stretched 3Global Graphene Manufacturing Leader, Graphene Frontiers, Receives Series Seed B Funding To Assure Production Of The Next Generation Of Biological And Chemical Sensor Technology 2
... and TOKYO, Aug. 15, 2011 A new post-hoc ... TRITON-TIMI 38 study – those identified as the "core ... (in combination with aspirin) was associated with a 26 ... of cardiovascular death, myocardial infarction or stroke, compared to ...
... team of researchers from the National Institute of ... the University of Maryland has made nano-sized sensors ... paints, cleaners, pesticides and other productsthat offer several ... room-temperature operation and the ability to detect one ...
... and portable detector that takes just fifteen minutes to ... being developed by US researchers. The technology amplifies any ... the presence of just 40 microscopic cells of the ... as anthrax, is a potentially lethal microbe that might ...
Cached Biology Technology:Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 2Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 3Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 4Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 5Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 6Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 7Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study 8Nanowire-based sensors offer improved detection of volatile organic compounds 2Nano detector for deadly anthrax 2
(Date:7/22/2014)... as a world-famous vacation spot with natural tourism resources, a ... The Korea Institute of Geoscience and Mineral Resources (KIGAM) indicated ... volcanic eruption was evident 5,000 years ago. That is the ... spewed out of a volcano 5,000 years ago in the ... the whole peninsula. , The research team led by Dr. ...
(Date:7/22/2014)... prevent their daughters from breeding, and kill their grandchildren ... desert creatures which live in groups with a dominant ... alpha female can flourish when it maintains the sole right ... life, also found in many animals such as ants and ... Dominant meerkats control breeding within their group through violence, by ...
(Date:7/22/2014)... July 22, 2014, Cleveland: A type of immune ... diseases, such as Alzheimer,s disease and multiple sclerosis ... brain injury (TBI) and may slow the progression ... published today in the online journal Nature ... Bruce Trapp, PhD, Chair of the Department of ...
Breaking Biology News(10 mins):Jeju Island is a live volcano 2Cleveland Clinic researchers discover neuroprotective role of immune cell 2
... (HLB), meaning "yellow shoot disease" in Chinese and ... the most destructive disease threatening the citrus industry ... are desired to control it. A new study, ... contributing factor in symptom expression for citrus Huanglongbing ...
... The Alfred P. Sloan Foundation is pleased to announce ... as recipients of Sloan Research Fellowships for 2013. ... to early-career scientists and scholars whose achievements and potential ... scientific leaders. "The Sloan Research Fellows are the ...
... Research Centre at Saint Mary,s Hospital and The University ... causing an inherited form of tumour, known as spinal ... Meningiomas are the commonest form of tumour affecting the ... surgery and do not recur. Occasionally people can develop ...
Cached Biology News:Phosphorus starvation linked to symptoms of citrus disease Huanglongbing in new study 2Phosphorus starvation linked to symptoms of citrus disease Huanglongbing in new study 3Sloan Foundation announces 2013 Sloan Research Fellows 2Researchers in Manchester find genetic key to preventing spine tumors 2
... stain has bright fluorescence when bound to dsDNA ... for detecting dsDNA in gels using laser scanners ... nucleic acid stain has also found uses ... bandshift assays. A 500 µL unit size (S-7563) ...
... cross-linking techniques are defined by the author ... Wong. This valuable hardcover guide includes hundreds ... application references. More than 300 pages detail ... conjugate preparation from selection and design ...
... protein separation by two-dimensional electrophoresis (2D-PAGE), ... package from Bio-Rad and protein identification ... to meet customers requirements regarding experimental ... format of the results permanent contact ...
... reagents for immune complex disruption (ICD) of ... using a combination of low pH and ... transferred to microplate wells which are coated ... to HIV-1 p24. The immobilized monoclonal antibody ...
Biology Products: